TWO · —

PharmaEngine, Inc. (4162.TWO) Stock

$56.20 -0.71% TWO: 4162.TWO —

—

Valuation

MetricValue
Price$56.20
Market Cap$7.87B
P/E Ratio14.65
P/B Ratio1.60
P/S Ratio7.68
EPS (TTM)$3.74
52-Week High$74.40
52-Week Low$53.00
Dividend Yield3.65%

Financials & Margins

MetricValue
ROE11.26%
ROA5.44%
ROCE—
Gross Margin93.87%
Operating Margin45.13%
Net Margin52.56%
Debt/Equity0.01
Current Ratio11.21

Latest News

Unpacking Q2 Earnings: Q2 Holdings (NYSE:QTWO) In The Context Of Other Vertical Software Stocks StockStory · Sep 8, 2026 LIV Golf files for bankruptcy protection AFP · Sep 8, 2026 Trinity Health to slash 557 workers at Livonia headquarters Detroit Free Press · Sep 8, 2026 Crown Capital Provides Bi-Weekly MCTO Default Status Report CNW Group · Sep 8, 2026 MYR Group Inc. to Attend KeyBanc Taking Charge: Energy Transition Symposium in September GlobeNewswire · Sep 8, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA5.83
FCF Yield—
Quick Ratio11.11
Interest Coverage—
Return 1Y-15.35%
Return 3Y-29.63%
Return 5Y17.40%

Ownership

Insiders Held21.60%
Institutions Held19.74%
Institutions Float Held25.18%

About PharmaEngine, Inc.

—

PharmaEngine, Inc. (4162.TWO) stock trades at $56.20 with a market capitalization of $7.87B. The stock is valued at a price-to-earnings (P/E) ratio of 14.65, price-to-book of 1.60, price-to-sales of 7.68. Over the past 52 weeks the stock has ranged between $53.00 and $74.40, and currently trades 24.5% below its 52-week high. It pays a dividend yielding 3.65%.

On profitability, PharmaEngine, Inc. generates a return on equity (ROE) of 11.26%, an operating margin of 45.13%, a net profit margin of 52.56%.

Official website: www.pharmaengine.com

PharmaEngine, Inc. (4162.TWO) — frequently asked questions

What is PharmaEngine, Inc. (4162.TWO) stock price today?

PharmaEngine, Inc. (4162.TWO) is currently trading at $56.20, down 0.71% today.

What is 4162.TWO P/E ratio?

PharmaEngine, Inc.'s P/E ratio is 14.65. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is 4162.TWO return on equity (ROE)?

PharmaEngine, Inc.'s return on equity (ROE) is 11.26%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is PharmaEngine, Inc.'s market cap?

PharmaEngine, Inc. has a market capitalization of $7.87B.

Does 4162.TWO pay a dividend?

Yes. PharmaEngine, Inc. currently yields 3.65%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 4162.TWO carry?

PharmaEngine, Inc. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 4162.TWO's profit margin?

PharmaEngine, Inc. reports a net profit margin of 52.56% — the share of revenue left after every cost, including tax and interest.

What sector is 4162.TWO in?

PharmaEngine, Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 4162.TWO listed on?

PharmaEngine, Inc. trades on TWO under the ticker 4162.TWO.

What is 4162.TWO's 52-week range?

Over the last year PharmaEngine, Inc. has traded between $53.00 and $74.40.

Related — Stocks

HONA Honeywell Aerospace Inc. $159.88 -9.69% USDE StablecoinX Inc. $1.00 -0.01% GENB Generate Biomedicines, Inc. $15.63 +22.20% GIXI Gix Internet Ltd. $4.10 +1.23%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 4162.TWO currently matches

On the figures above, PharmaEngine, Inc. passes the filters for 20 of our ready-made screens, among them Undervalued Stocks, Undervalued Dividend Stocks, Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Undervalued StocksUndervalued Dividend StocksDividend StocksLow Debt Dividend StocksLow Debt StocksHigh Profit Margin StocksStocks With Insider BuyingStocks With PE Under 20Debt Free Stocks Under $100Debt Free StocksHigh Margin Dividend StocksStocks Under $100High Gross Margin StocksDividend Yield Over 3%Mid Cap StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio StocksDebt Free Low PE Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.